Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

Abstract Introduction Hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) are associated with significant healthcare resource utilization (HCRU). This a priori, exploratory, secondary analysis from the ASPECT-NP clinical trial evaluated resource utilization among patients...

Full description

Bibliographic Details
Main Authors: Thomas Lodise, Joe Yang, Laura A. Puzniak, Ryan Dillon, Marin Kollef
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-09-01
Series:Infectious Diseases and Therapy
Subjects:
Ceftolozane/tazobactam
Hospital-acquired bacterial pneumonia
Hospitalization
Mechanical ventilation
Meropenem
Multidrug resistance
Online Access:https://doi.org/10.1007/s40121-020-00343-0

Internet

https://doi.org/10.1007/s40121-020-00343-0

Similar Items